Next earnings date: 12 Aug 2025
Yield10 Bioscience, Inc. – NASDAQ:YTEN
Yield10 Bioscience stock price today
Yield10 Bioscience stock price monthly change
Yield10 Bioscience stock price quarterly change
Yield10 Bioscience stock price yearly change
Yield10 Bioscience key metrics
Market Cap | 345.46K |
Enterprise value | 15.91M |
P/E | -1.05 |
EV/Sales | 35.36 |
EV/EBITDA | -1.21 |
Price/Sales | 34.71 |
Price/Book | 3.55 |
PEG ratio | 0.05 |
EPS | -36.68 |
Revenue | N/A |
EBITDA | -12.90M |
Income | -13.14M |
Revenue Q/Q | 400% |
Revenue Y/Y | -0.27% |
Profit margin | -3014.67% |
Oper. margin | -2989.11% |
Gross margin | 42.22% |
EBIT margin | -2989.11% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeYield10 Bioscience stock price history
Yield10 Bioscience stock forecast
Yield10 Bioscience financial statements
| Jun 2023 | 0 | -3.68M | |
|---|---|---|---|
| Sep 2023 | 0 | -3.72M | |
| Dec 2023 | 60K | -3.26M | -5443.33% |
| Mar 2024 | 300K | -2.47M | -824% |
| Mar 2024 | 300K | -2.47M | -824% |
|---|---|---|---|
| Sep 2025 | 1.5M | -2.16M | -144.39% |
| Oct 2025 | 1.5M | -2.24M | -149.34% |
| Dec 2025 | 2.5M | -2.61M | -104.54% |
Analysts Price target
Financials & Ratios estimates
| 2024-08-14 | -3.96 | -5.04 |
|---|
| Jun 2023 | 5870000 | 5.28M | 90% |
|---|---|---|---|
| Sep 2023 | 6042000 | 5.65M | 93.51% |
| Dec 2023 | 3907000 | 6.39M | 163.55% |
| Mar 2024 | 4243000 | 7.55M | 178.08% |
| Jun 2023 | -3.07M | -18K | 3.63M |
|---|---|---|---|
| Sep 2023 | -2.61M | 1K | 3.09M |
| Dec 2023 | -1.71M | -20K | 0 |
| Mar 2024 | -903K | 0 | 1.21M |
Yield10 Bioscience alternative data
| Aug 2023 | 30 |
|---|---|
| Sep 2023 | 30 |
| Oct 2023 | 30 |
| Nov 2023 | 30 |
| Dec 2023 | 30 |
| Jan 2024 | 30 |
| Feb 2024 | 30 |
| Mar 2024 | 30 |
| Apr 2024 | 30 |
| May 2024 | 29 |
| Jun 2024 | 29 |
| Jul 2024 | 29 |
Yield10 Bioscience other data
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 671140 | 0 |
| Oct 2023 | 0 | 90000 |
| Dec 2023 | 0 | 71000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | SCHULER JACK W 10 percent owner | Common Stock | 36,000 | $0.21 | $7,416 | ||
Sale | SCHULER JACK W 10 percent owner | Common Stock | 35,000 | $0.24 | $8,330 | ||
Sale | SCHULER JACK W 10 percent owner | Common Stock | 37,931 | $0.3 | $11,455 | ||
Sale | SCHULER JACK W 10 percent owner | Common Stock | 10,670 | $0.3 | $3,212 | ||
Sale | SCHULER JACK W 10 percent owner | Common Stock | 41,399 | $0.31 | $12,875 | ||
Purchase | SCHULER JACK W 10 percent owner | Common Stock Warrants | 335,570 | $2.98 | $999,999 | ||
Purchase | SCHULER JACK W 10 percent owner | Common Stock | 335,570 | $2.98 | $999,999 | ||
Purchase | SINSKEY ANTHONY J director | Common Stock | 2,000 | $2.8 | $5,600 | ||
Purchase | SINSKEY ANTHONY J director | Common Stock | 2,000 | $2.85 | $5,698 | ||
Purchase | SINSKEY ANTHONY J director | Common Stock | 2,000 | $2.77 | $5,530 |
| Patent |
|---|
Application MODIFIED PLANTS COMPRISING A POLYNUCLEOTIDE COMPRISING A NON-COGNATE PROMOTER OPERABLY LINKED TO A CODING SEQUENCE THAT ENCODES A TRANSCRIPTION FACTOR Filling date: 13 May 2020 Issue date: 28 Jul 2022 |
Application Filling date: 11 Oct 2021 Issue date: 27 Jan 2022 |
Application GENETICALLY ENGINEERED LAND PLANTS THAT EXPRESS AN INCREASED SEED YIELD PROTEIN AND/OR AN INCREASED SEED YIELD RNA Filling date: 3 Sep 2019 Issue date: 11 Nov 2021 |
Application Filling date: 24 Mar 2021 Issue date: 28 Oct 2021 |
Application Filling date: 10 Oct 2019 Issue date: 28 Oct 2021 |
Grant Filling date: 13 Sep 2019 Issue date: 27 Jul 2021 |
Application Filling date: 15 Jun 2018 Issue date: 20 May 2021 |
Application Filling date: 1 Apr 2019 Issue date: 13 May 2021 |
Application GENETICALLY ENGINEERED LAND PLANTS THAT EXPRESS LCID/E PROTEIN AND OPTIONALLY A CCP1 MITOCHONDRIAL TRANSPORTER PROTEIN AND/OR PYRUVATE CARBOXYLASE Filling date: 26 Nov 2018 Issue date: 26 Nov 2020 |
Application Filling date: 2 Nov 2018 Issue date: 5 Nov 2020 |
| Quarter | Transcript |
|---|---|
| Q4 2023 1 Apr 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 14 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 14 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 10 May 2023 | Q1 2023 Earnings Call Transcript |
-
What's the price of Yield10 Bioscience stock today?
One share of Yield10 Bioscience stock can currently be purchased for approximately $1.39.
-
When is Yield10 Bioscience's next earnings date?
Yield10 Bioscience, Inc. is estimated to report earnings on Tuesday, 12 Aug 2025.
-
Does Yield10 Bioscience pay dividends?
No, Yield10 Bioscience does not pay dividends.
-
How much money does Yield10 Bioscience make?
Yield10 Bioscience has a market capitalization of 345.46K and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 86.67% to 60K US dollars. Yield10 Bioscience made a loss 14.46M US dollars in net income (profit) last year or -$5.04 on an earnings per share basis.
-
What is Yield10 Bioscience's stock symbol?
Yield10 Bioscience, Inc. is traded on the NASDAQ under the ticker symbol "YTEN".
-
What is Yield10 Bioscience's primary industry?
Company operates in the Basic Materials sector and Agricultural Inputs industry.
-
How do i buy shares of Yield10 Bioscience?
Shares of Yield10 Bioscience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Yield10 Bioscience's key executives?
Yield10 Bioscience's management team includes the following people:
- Dr. Oliver P. Peoples Co-Founder, Pres, Chief Executive Officer & Director(age: 67, pay: $434,400)
- Dr. Kristi D. Snell Vice President of Research & Chief Science Officer(age: 57, pay: $322,070)
- Ms. Lynne H. Brum Vice President of Planning & Corporation Communications and Sec.(age: 61, pay: $312,080)
- Dr. Anthony J. Sinskey Ph.D., Sc.D. Co-Founder & Independent Director(age: 85, pay: $59,780)
-
Is Yield10 Bioscience founder-led company?
Yes, Yield10 Bioscience is a company led by its founders Dr. Oliver P. Peoples and Dr. Anthony J. Sinskey Ph.D., Sc.D..
-
How many employees does Yield10 Bioscience have?
As Jul 2024, Yield10 Bioscience employs 29 workers, which is 3% less then previous quarter.
-
When Yield10 Bioscience went public?
Yield10 Bioscience, Inc. is publicly traded company for more then 18 years since IPO on 10 Nov 2006.
-
What is Yield10 Bioscience's official website?
The official website for Yield10 Bioscience is yield10bio.com.
-
Where are Yield10 Bioscience's headquarters?
Yield10 Bioscience is headquartered at 19 Presidential Way, Woburn, MA.
-
How can i contact Yield10 Bioscience?
Yield10 Bioscience's mailing address is 19 Presidential Way, Woburn, MA and company can be reached via phone at +61 75831700.
Yield10 Bioscience company profile:
Yield10 Bioscience, Inc.
yield10bio.comNASDAQ
29
Agricultural Inputs
Basic Materials
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
Woburn, MA 01801
CIK: 0001121702
ISIN: US98585K8624
CUSIP: 98585K862
